[go: up one dir, main page]

AR009282A1 - INTEGRINE BETA2-MEDIATED CELL ADHESION MOLECULAR INHIBITORS - Google Patents

INTEGRINE BETA2-MEDIATED CELL ADHESION MOLECULAR INHIBITORS

Info

Publication number
AR009282A1
AR009282A1 ARP970103784A ARP970103784A AR009282A1 AR 009282 A1 AR009282 A1 AR 009282A1 AR P970103784 A ARP970103784 A AR P970103784A AR P970103784 A ARP970103784 A AR P970103784A AR 009282 A1 AR009282 A1 AR 009282A1
Authority
AR
Argentina
Prior art keywords
cell adhesion
beta2
integrine
mediated cell
molecular inhibitors
Prior art date
Application number
ARP970103784A
Other languages
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR009282A1 publication Critical patent/AR009282A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones y métodos, que utilizan un compuesto de formula (I) para reducir o controlar la inflamacion y el tratamiento de estados patologicosmediados por la adhesion intracelular. Más particularmente, la presente invencion se refierea composiciones y métodos para bloquear o modular lafuncion de la familia de integrina Beta2 en moléculas de adhesion celular.Compositions and methods, which use a compound of formula (I) to reduce or control inflammation and the treatment of pathological conditions mediated by intracellular adhesion. More particularly, the present invention relates to compositions and methods for blocking or modulating the function of the Beta2 integrin family in cell adhesion molecules.

ARP970103784A 1996-08-21 1997-08-20 INTEGRINE BETA2-MEDIATED CELL ADHESION MOLECULAR INHIBITORS AR009282A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70111396A 1996-08-21 1996-08-21

Publications (1)

Publication Number Publication Date
AR009282A1 true AR009282A1 (en) 2000-04-12

Family

ID=24816122

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103784A AR009282A1 (en) 1996-08-21 1997-08-20 INTEGRINE BETA2-MEDIATED CELL ADHESION MOLECULAR INHIBITORS

Country Status (4)

Country Link
AR (1) AR009282A1 (en)
AU (1) AU4152297A (en)
WO (1) WO1998007432A1 (en)
ZA (1) ZA977471B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
ES2147163B1 (en) 1999-01-25 2001-03-01 Esp Farmaceuticas Centrum Sa A PHARMACEUTICAL COMPOSITION WITH REGULATORY ACTIVITY OF THE EXPRESSION OF THE ADHESION MOLECULES.

Also Published As

Publication number Publication date
AU4152297A (en) 1998-03-06
WO1998007432A1 (en) 1998-02-26
ZA977471B (en) 1999-02-22

Similar Documents

Publication Publication Date Title
BR0109188A (en) Substituted 5-Amide Diarylamines as Mex Inhibitors
BR9811099A (en) Urokinase inhibitors
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
DK0806933T3 (en) Preparations and methods for reducing skin irritation
BR0309278A (en) Compound, composition, methods for modulating ksp kinesin activity, for inhibiting ksp, for the treatment of a cell proliferative disease, and use of a compound
ES2196630T3 (en) ISOTIAZOLCARBOXIAMIDAS AND ITS EMPLOYMENT FOR THE PROTECTION OF PLANTS.
NO994877L (en) Calcilitic compounds
BRPI0410348A (en) compounds and uses thereof in amyloid-beta modulation
ATE193883T1 (en) COMPOUNDS AND THEIR COMPOSITIONS HAVING ANTI-INFLAMMATORY AND ANTI-THROMBOTIC ACTIONS
DE69633679D1 (en) SUBSTITUTED ARYL OR HETEROARYLAMID WITH RETINOID-LIKE BIOLOGICAL ACTIVITY
HUP9900936A1 (en) Isocyanate compositions, method for using same, use thereof for producing coatings, and resulting coatings
BR0207278A (en) Phthalazinone-piperidine derivatives as pde4 inhibitors
BR9903571A (en) Method for inhibiting human glycogen phosphorylase
BR0011172A (en) 4,5-diaryl-3 (2h) -furanone derivatives as cliclooxygenase-2 inhibitors
BR9811948A (en) Growth hormone secretors
TR199801579T2 (en) Insecticidal compositions based on polymers.
BR0001201A (en) (Poly) thiaalkinoic compound, cosmetic composition, use of a cosmetic composition, use of a compound and pharmaceutical composition
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
DK1053000T3 (en) Means and methods for the protection, treatment and repair of connective tissue
ATE516027T1 (en) ORAZAMID OROTAT TO PREVENT LIVER DAMAGE
AR009282A1 (en) INTEGRINE BETA2-MEDIATED CELL ADHESION MOLECULAR INHIBITORS
NZ516620A (en) 1,4-substituted 4,4-diaryl cyclohexanes
BR9814188A (en) "5-ht1f agonists"
BR9712307A (en) Pyrazolinones for the treatment of weakened potency
WO2002006280A3 (en) INHIBITORS OF FACTOR Xa